In our second case, we demonstrated a patient with low ADAMTS13 activity and anti-ADAMTS13 antibodies with proven breast adenocarcinoma, so vigorously searching for possible tumours should be performed even in cases with low ADAMTS13. This evidence concerns the gene ADAMTS13 and breast adenocarcinoma.